Extranodal Marginal Zone Lymphoma clinical trials

Explore recruiting extranodal marginal zone lymphoma clinical trials.

Recruiting extranodal marginal zone lymphoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Extranodal Marginal Zone Lymphoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A PHASE II STUDY OF CHLORAMBUCIL IN COMBINATION WITH SUBCUTANEOUS RITUXIMAB FOLLOWED BY MAINTENANCE THERAPY WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT LYMPHOMA)

France, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Extranodal Marginal Zone Lymphoma trials by city

Extranodal Marginal Zone Lymphoma clinical trials

Recruiting extranodal marginal zone lymphoma studies right now

Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Zanubrutinib in Combination With Sonrotoclax for the Treatment of Underrepresented Ethnic and Racial Minorities With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

The Treatment of Ocular Adnexal Extranodal Marginal Zone B-cell Lymphoma by Orelabrutinib and Radiotherapy

Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)

Also recruiting in Europe

A PHASE II STUDY OF CHLORAMBUCIL IN COMBINATION WITH SUBCUTANEOUS RITUXIMAB FOLLOWED BY MAINTENANCE THERAPY WITH SUBCUTANEOUS RITUXIMAB IN PATIENTS WITH EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA OF MUCOSA ASSOCIATED LYMPHOID TISSUE (MALT LYMPHOMA)

Extranodal Marginal Zone Lymphoma trials by city

Other conditions